Avantor has announced that, in partnership with Amgen, it has received a 2025 Edison Patent Award from the Research & Development Council of New Jersey.
The recognition was for their pioneering development of a biodegradable detergent that enables safer, more sustainable viral inactivation in biomanufacturing.
Co-developed by Avantor and Amgen, Avantor's detergent delivers effective viral inactivation while maintaining protein integrity and increasing process yield.
This jointly developed technology addresses a critical industry challenge by providing a compliant, high-performing and environmentally responsible alternative for producing monoclonal antibodies, vaccines and gene therapies.
"We are honoured to be recognised by the R&D Council of New Jersey for this achievement," said Benoit Gourdier, Executive Vice President, Bioscience Production, Avantor.
"Our collaboration demonstrates how strategic partnerships can drive scientific innovation and environmental responsibility to advance biomanufacturing."
"By developing safer, more effective detergents, Avantor is supporting our customers in producing vital therapies responsibly and with less impact on the environment."
Co-developed at Avantor's Bridgewater Innovation Centre, this work strengthens Avantor's leadership in sustainable bioprocessing while showcasing the power of industry collaboration.
The partnership also reinforces New Jersey's position as a global hub for scientific innovation and sustainable technology.